Anavex Life Sciences (AVXL) Tops Q3 EPS by 3c

Anavex Life Sciences (NASDAQ: AVXL) reported Q3 EPS of ($0.14), $0.03 better than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Anavex Life Sciences (AVXL) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Hyperscale Data launches $300M at-the-market stock offering
• JPMorgan Upgrades SHIFT UP Corp (462870:KS) to Overweight